US 9364505
Therapeutic composition for treatment of glioblastoma
granted A61KA61K2039/54A61K2039/55511
Quick answer
US patent 9364505 (Therapeutic composition for treatment of glioblastoma) held by Regents of the University of Minnesota expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/54, A61K2039/55511, A61K2039/575, A61K2239/31